The Doris Duke Charitable Foundation announced recently its first grant awards, totaling more than $4.2 million, under the Doris Duke Clinical Scientist Award Program. The program was developed to enable promising young scientists conducting research in cancer, heart disease, AIDS, sickle cell anemia, and other blood disorders to pursue careers in clinical investigation.
Although the Foundation initially planned to award up to 10 individual grants, its peer review panel recommended funding 14 scientists at $100,000 each for 3 years. An additional 2 years of support will be considered based on the investigator’s access to other funding sources and his/her record of independent scientific accomplishment.
Award Program Extended
The Foundation’s Board of Trustees has voted to extend the Clinical Scientist Award Program for another year. Applications for the 1999 awards will be available in the fall.
"We are encouraged and pleased that the quality of the proposals we received was so high that our independent peer review panel recommended an increase in the number of awards," said Joan E. Spero, President of the Foundation. "The projects we are funding clearly reflect Doris Duke’s intentions that we focus on promising young researchers working in these four critical areas of medicine."
The Awardees
The deans of medical institutions nominated the applicants, with no more than two nominations accepted from each institution. A list of award-winners follows.
Awards for AIDS research were given to:
Rany Condos, MD, New York University Medical Center for Aerosol IFN-y Treatment to Promote The Response in TB/AIDS
Andrew D. Badley, MD Ottawa (Canada) General Hospital for Pathophysiologic Role of Enhanced Fas Susceptibility and Fas Ligand Production in Pathogenesis of HI V Disease
William E. Cunningham, MD, MPH, UCLA School of Public Health for AIDS Health Outcomes and Access to Medical Care
Michael E. Hagensee, MD, PhD, Louisiana State University School of Medicine for Predictors of Cervical Dysplasia in HIV-Infected Women
Grants for research on sickle cell disease and other blood disorders went to:
Marshall S. Horwitz, MD, PhD, University of Washington School of Medicine for Familial Leukemia
Alison R. Moliterno, MD, Johns Hopkins University School of Medicine for The Role of the Thrombopoietin Receptor in Myeloproliferative Disorders
Jonathan G. Drachman, MD, University of Washington School of Medicine for The Molecular Basis of Inherited Thrombocytopenia
Eleanor S. Pollak, MD, Children’s Hospital of Philadelphia for Regulation of Expression of Procoagulant Proteins Prothrombin and Factor VII
Cancer research grant recipients were:
Howard L. Kaufman, MD, Albert Einstein College of Medicine for Clinical and Transgenic Models/or Cancer Vaccines
Edmund K. Waller, MD, PhD, Emory University School of Medicine for Enhancing Immune Reconstitution in Cancer Patients
James D. Brooks, MD, Stanford University School of Medicine for Prostate Cancer Prevention through Induction of Phase Two Enzymes
Jennifer J. Griggs,MD, University of Rochester School of Medicine for Racial Variations in Chemotherapy for Breast Cancer
The awardees of cardiovascular disease research grants included:
Daniel M. Bloomfield, MD, College of Physicians and Surgeons of Columbia University for Prevalence and Prognostic Significance of T Wave Alternans
Alison E. Bard, MBBS, FRACP, PhD, Beth Israel Deaconess Medical Center for Multimodality Magnetic Resonance Imaging in Acute Stroke
The Doris Duke Clinical Scientist Award Program is overseen by a Scientific Advisory Council chaired by James B. Wyngaarden, former director of the National Institutes of Health (NIH).
A 48-year-old female presents with complaints of irregular vaginal bleeding and postcoital bleeding. Images from a PET/CT and pelvis MRI reveal characteristic findings. What is your diagnosis?
